Medicines in Development: According to the latest Medicines In Development report, America’s biopharmaceutical research companies are currently developing 836 medicines and vaccines to treat various cancers. Learn more about this promising pipeline here.
Biopharmaceutical Patents: The patent system is critical to achieving research and development breakthroughs, treatments and cures. Check out a new infographic for 5 reasons why biopharmaceutical patents are different than those in other industries.
Medicaid Adherence Yields Savings: A new study co-authored by PhRMA and published in the latest edition of Health Affairs found that improved adherence by Medicaid beneficiaries can reduce U.S. medical costs by reducing expensive hospitalizations and emergency room visits. Find out more here.
Value at the Crossroads: Frameworks and tools that seek to assess the value of certain treatment options are gaining increased attention. Learn more about the significant implications these tools hold and the importance of ensuring informed decision-making by patients and health care providers remains intact.
Medicare Monday: Take a look at this week’s post for resources for understanding Medicare Part B and D.
Priscilla VanderVeer Priscilla VanderVeer Priscilla VanderVeer is a vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Annapolis, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.